Algert Global LLC Karuna Therapeutics, Inc. Transaction History

Algert Global LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$161.01 - $317.85 $684,292 - $1.35 Million	-4,250 Reduced 23.07%	14,176 $4.49 Million
Q3 2023 Nov 13, 2023	BUY	$164.66 - $218.08 $1.93 Million - $2.56 Million	11,730 Added 175.18%	18,426 $3.12 Million
Q2 2023 Aug 14, 2023	SELL	$176.32 - $240.22 $1.77 Million - $2.41 Million	-10,030 Reduced 59.97%	6,696 $1.45 Million
Q1 2023 May 12, 2023	BUY	$161.33 - $204.36 $1.27 Million - $1.61 Million	7,871 Added 88.89%	16,726 $3.04 Million
Q4 2022 Feb 13, 2023	BUY	$191.53 - $236.82 $172,377 - $213,138	900 Added 11.31%	8,855 $1.74 Million
Q3 2022 Nov 15, 2022	BUY	$123.79 - $277.42 $719,715 - $1.61 Million	5,814 Added 271.56%	7,955 $1.79 Million
Q1 2022 May 16, 2022	BUY	$98.9 - $132.37 $211,744 - $283,404	2,141 New	2,141 $271,000

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.